BR112015029987A8 - Beta-caseína a2 e a prevenção de inflamação do intestino - Google Patents

Beta-caseína a2 e a prevenção de inflamação do intestino

Info

Publication number
BR112015029987A8
BR112015029987A8 BR112015029987A BR112015029987A BR112015029987A8 BR 112015029987 A8 BR112015029987 A8 BR 112015029987A8 BR 112015029987 A BR112015029987 A BR 112015029987A BR 112015029987 A BR112015029987 A BR 112015029987A BR 112015029987 A8 BR112015029987 A8 BR 112015029987A8
Authority
BR
Brazil
Prior art keywords
beta
casein
prevention
intestinal inflammation
inflammation
Prior art date
Application number
BR112015029987A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112015029987A2 (pt
Inventor
John Clarke Andrew
Suchin Trivedi Malav
Original Assignee
A2 Milk Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51989162&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112015029987(A8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by A2 Milk Co Ltd filed Critical A2 Milk Co Ltd
Publication of BR112015029987A2 publication Critical patent/BR112015029987A2/pt
Publication of BR112015029987A8 publication Critical patent/BR112015029987A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Animal Husbandry (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Confectionery (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112015029987A 2013-05-31 2014-05-30 Beta-caseína a2 e a prevenção de inflamação do intestino BR112015029987A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361829764P 2013-05-31 2013-05-31
PCT/NZ2014/000102 WO2014193248A1 (en) 2013-05-31 2014-05-30 Beta-casein a2 and prevention of inflammation of the bowel

Publications (2)

Publication Number Publication Date
BR112015029987A2 BR112015029987A2 (pt) 2017-07-25
BR112015029987A8 true BR112015029987A8 (pt) 2021-12-07

Family

ID=51989162

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015029987A BR112015029987A8 (pt) 2013-05-31 2014-05-30 Beta-caseína a2 e a prevenção de inflamação do intestino

Country Status (19)

Country Link
US (2) US20160113997A1 (enExample)
EP (2) EP3003485B1 (enExample)
JP (2) JP6867158B2 (enExample)
KR (2) KR102282972B1 (enExample)
CN (2) CN112316116A (enExample)
AU (2) AU2014271423B2 (enExample)
BR (1) BR112015029987A8 (enExample)
CA (1) CA2913890C (enExample)
CL (1) CL2015003507A1 (enExample)
DK (1) DK3003485T3 (enExample)
ES (1) ES2742306T3 (enExample)
IL (2) IL242833B (enExample)
MX (2) MX367794B (enExample)
MY (1) MY179497A (enExample)
PH (2) PH12015502674B1 (enExample)
RU (1) RU2669553C2 (enExample)
SG (2) SG10201709509RA (enExample)
WO (1) WO2014193248A1 (enExample)
ZA (1) ZA201508983B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015029987A8 (pt) * 2013-05-31 2021-12-07 A2 Milk Co Ltd Beta-caseína a2 e a prevenção de inflamação do intestino
KR102291660B1 (ko) * 2013-07-12 2021-08-19 디 에이2 밀크 컴퍼니 리미티드 락토스 불내증의 증상을 감소시키거나 예방하는 베타-카세인 a2
GB2519101A (en) * 2013-10-09 2015-04-15 Nicoventures Holdings Ltd Electronic vapour provision system
US20170086481A1 (en) * 2014-06-03 2017-03-30 Abbott Laboratories Nutritional compositions comprising a lipophilic active ingredient
MX392728B (es) * 2015-05-22 2025-03-24 A2 Milk Co Ltd Beta-caseina a2 y su capacidad antioxidante.
WO2017003300A1 (en) * 2015-06-29 2017-01-05 The A2 Milk Company Limited A2 beta-casein and viscosity of milk products
CA3017727C (en) 2016-03-30 2024-03-12 The A2 Milk Company Limited Beta-caseins and cognitive function
AU2016424981C1 (en) * 2016-09-30 2024-10-10 The A2 Milk Company Limited Beta-caseins and gut microbiota
EP3526201B1 (en) * 2016-10-14 2020-11-18 H. Hoffnabb-La Roche Ag Imidazole compounds as eaat3 inhibitors
NL2019906B1 (en) * 2017-11-14 2019-05-20 Ausnutria Hyproca B V Composition comprising a2 b-casein and a vegetable fat mixture
CN112205476A (zh) * 2019-07-11 2021-01-12 北京三元食品股份有限公司 β-酪蛋白A2、其组合物在促进双歧杆菌属增殖中的应用
WO2021003741A1 (zh) * 2019-07-11 2021-01-14 北京三元食品股份有限公司 β-酪蛋白A2、其组合物在促进双歧杆菌属增殖中的应用
CN115708530B (zh) * 2022-11-15 2024-08-09 北大荒完达山乳业股份有限公司 一种促进消化舒适性并稳定血糖的孕产妇配方奶粉及其制备方法
CN117322467A (zh) * 2023-10-11 2024-01-02 东北农业大学 A2β-酪蛋白在制备功能性食品中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE442585T1 (de) 1994-11-04 2009-09-15 A2 Corp Ltd Selektionsverfahren für nicht-diabetogene milch oder milchprodukte sowie hierdurch erfasste milch oder milchprodukte
CA2217820C (en) 1995-05-16 2011-03-01 Corran Norman Stuart Mclachlan Milk and milk products for preventing or treating heart disease
NZ306584A (en) * 1995-05-16 2000-02-28 Corran Norman Stuart Mclachlan Milk or dairy products derived from animals and which are free of beta casein
AU4266100A (en) * 1995-05-16 2000-10-12 Corran Norman Stuart Mclachlan Food product and process
US6570060B2 (en) 1995-05-16 2003-05-27 Mclachlan Corran Norman Stuart Milk lacking β-casein A1
AU771754B2 (en) * 1999-06-29 2004-04-01 New Zealand Milk Institute Limited, The Prophylactic dietary supplement based on milk
NZ516712A (en) * 1999-06-29 2003-10-31 New Zealand Milk Inst Ltd Prophylactic dietary supplement based on milk
WO2002019832A1 (en) 2000-09-08 2002-03-14 New Zealand Dairy Board MILK CONTAINING β-CASEIN WITH PROLINE AT POSITION 67 DOES NOT AGGRAVATE NEUROLOGICAL DISORDERS
WO2002083164A2 (en) * 2001-04-10 2002-10-24 Societe Des Produits Nestle S.A. Method and composition for prophylaxis of diabetes
US20060280802A1 (en) * 2002-10-04 2006-12-14 Campbell Julie H Therapeutic uses of beta-casein a2 and dietary supplement containing beta-casein a2
US7481127B2 (en) 2004-09-27 2009-01-27 Lester William T Continuously variable transmission using oscillating torque and one-way drives
WO2008041219A1 (en) * 2006-10-06 2008-04-10 Kerry Group Services International Limited A milk protein composition and use thereof
US8871276B2 (en) * 2008-02-11 2014-10-28 Technion Research And Development Foundation Ltd. Beta-casein assemblies for mucosal delivery of therapeutic bioactive agents
TWI516269B (zh) * 2009-08-14 2016-01-11 禾伸堂生技股份有限公司 使用於炎症性腸疾病（ｉｂｄ）治療和預防之透明質酸混合物
BR112015029987A8 (pt) * 2013-05-31 2021-12-07 A2 Milk Co Ltd Beta-caseína a2 e a prevenção de inflamação do intestino
KR102291660B1 (ko) * 2013-07-12 2021-08-19 디 에이2 밀크 컴퍼니 리미티드 락토스 불내증의 증상을 감소시키거나 예방하는 베타-카세인 a2

Also Published As

Publication number Publication date
BR112015029987A2 (pt) 2017-07-25
CL2015003507A1 (es) 2016-12-16
AU2014271423B2 (en) 2018-12-20
RU2018131733A (ru) 2018-11-08
AU2018274937B2 (en) 2020-10-29
MX2015016493A (es) 2016-08-18
US20160113997A1 (en) 2016-04-28
CN105407971B (zh) 2020-11-17
EP3003485B1 (en) 2019-05-15
MY179497A (en) 2020-11-09
ES2742306T3 (es) 2020-02-13
KR102282972B1 (ko) 2021-07-28
CA2913890C (en) 2024-09-10
MX367794B (es) 2019-09-06
RU2018131733A3 (enExample) 2021-10-29
KR20160024884A (ko) 2016-03-07
NZ714912A (en) 2021-06-25
WO2014193248A1 (en) 2014-12-04
SG11201509769QA (en) 2015-12-30
MX2019010594A (es) 2019-10-15
PH12015502674A1 (en) 2016-03-07
IL242833B (en) 2019-07-31
JP2019165746A (ja) 2019-10-03
IL262302B (en) 2021-02-28
PH12019550096A1 (en) 2020-02-10
EP3542813A1 (en) 2019-09-25
KR102402455B1 (ko) 2022-05-25
MX391963B (es) 2025-03-21
CA2913890A1 (en) 2014-12-04
RU2669553C2 (ru) 2018-10-12
SG10201709509RA (en) 2017-12-28
CN105407971A (zh) 2016-03-16
JP6867158B2 (ja) 2021-04-28
EP3003485A1 (en) 2016-04-13
IL262302A (en) 2018-11-29
RU2015153113A (ru) 2017-07-05
JP7224242B2 (ja) 2023-02-17
HK1222362A1 (en) 2017-06-30
US20200179485A1 (en) 2020-06-11
PH12015502674B1 (en) 2020-02-21
ZA201508983B (en) 2017-11-29
KR20210094674A (ko) 2021-07-29
AU2014271423A1 (en) 2015-12-24
US11911439B2 (en) 2024-02-27
CN112316116A (zh) 2021-02-05
AU2018274937A1 (en) 2019-01-03
DK3003485T3 (da) 2019-08-19
EP3003485A4 (en) 2016-11-30
JP2016520611A (ja) 2016-07-14

Similar Documents

Publication Publication Date Title
BR112015029987A8 (pt) Beta-caseína a2 e a prevenção de inflamação do intestino
BR112017017217A2 (pt) ?composição que compreende ramnolipídeo e siloxano?
DOP2016000125A (es) MODULADORES DE ROR GAMMA (RORy)
BR112018006368A2 (pt) composição para desempenho melhorado
BR112019000338A2 (pt) composições compreendendo cepas bacterianas
BR112016008409A2 (pt) Uso de um agente inibidor de masp-2 que inibe a ativação de complemento dependente de masp-2
UY37036A (es) Compuestos inhibidores de la quinasa de unión a tank
BR112017005693A2 (pt) método para tratar e/ou prevenir uma doença hepática, e, composição farmacêutica.
BR112016015851A2 (pt) Formulações farmacêuticas estabilizadas de insulina aspart
BR112016000612B8 (pt) Uso de leite na fabricação de uma composição para prevenir ou reduzir os sintomas de intolerância a lactose
BR112015023387A2 (pt) composições lipídicas de racecodotril
BR112017013770A2 (pt) composições de inibidor de nitrificação microencapsuladas
UY35276A (es) Nuevos compuestos que inhiben la actividad de Lp-PLA2
BR112015017608A2 (pt) Composto de rotulagem
BR112015025787A8 (pt) composição para o tratamento e/ou pós-tratamento do câncer e uso de uma combinação de óleo de peixe e suco na fabricação de tal composição
BR102015012091A8 (pt) método para a preparação de uma solução de albumina humana, e, composição
BR112017010218A2 (pt) placa de gesso.
BR112018011763A2 (pt) composição de combustível para aviação
BR112015011759A2 (pt) composição simbiótica e uso da mesma
MX2017009929A (es) Composiciones y métodos para metabolismo muscular mejorado.
BR112016012552A8 (pt) derivado de cromona como um antagonista do receptor d3 de dopamina, seu uso e sua composição farmacêutica
BR112016028922A8 (pt) composição na forma de partículas compactadas e uso da mesma
BR112018068817A2 (pt) beta-caseínas e função cognitiva
BR112014018850A8 (pt) Composição e sua utilização no tratamento de rágades anais
BR112019008389A2 (pt) novas composições ativas em adipócitos

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B350 Update of information on the portal [chapter 15.35 patent gazette]
B25G Requested change of headquarter approved

Owner name: THE A2 MILK COMPANY LIMITED (NZ)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]